pediflow and nuflow - cpap/bipap nasal mask, single-use
device technologies australia pty ltd -
neonatal cpap unit
getinge australia pty ltd -
lutathera 370 mbqml solution for infusion
novartis israel ltd - lutetium (177lu) oxodotreotide - solution for infusion - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide - lutathera is indicated for the treatment of unresectable or metastatic, progressive, well differentiated (g1 and g2), somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours (gep nets) in adults.
lutathera 370 mbqml solution for infusion
marshall isotope ltd, israel - lutetium (177lu) oxodotreotide - solution for infusion - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide - lutathera is indicated for the treatment of unresectable or metastatic, progressive, well differentiated (g1 and g2), somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours (gep nets) in adults.
lutathera 370 mbqml solution for infusion
marshall isotope ltd, israel - lutetium (177lu) oxodotreotide - solution for infusion - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide - lutathera is indicated for the treatment of unresectable or metastatic, progressive, well differentiated (g1 and g2), somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours (gep nets) in adults.
mask, air/oxygen
getinge australia pty ltd -
omeprazol heumann 20 mg magensaftresistente hartkapseln
losartan-ratiopharm comp. 100 mg/25 mg filmtabletten
flurbiprofen dexcel 8,75 mg/dosis spray zur anwendung in der mundhöhle
moxiclav duo 500/125 and moxiclav duo forte 875/125
southern cross pharma pty ltd - potassium clavulanate; amoxicillin trihydrate -